Literature DB >> 6875756

99mTc-HIDA cholescintigraphy in children with Dubin-Johnson syndrome.

Y Bujanover, S Bar-Meir, I Hayman, J Baron.   

Abstract

Tc-HIDA cholescintigraphy in Dubin-Johnson syndrome (DJS) demonstrates intense prolonged homogeneous visualization of the liver, together with delayed visualization of the gall bladder and extrahepatic ducts. Such a cholescintigram has not been described for any other hyperbilirubinemic state. Because it is a noninvasive and easy technique, it is recommended for the evaluation of children suspected of having DJS.

Entities:  

Mesh：

Substances：

Year:  1983        PMID： 6875756

Source DB:  PubMed          Journal:  J Pediatr Gastroenterol Nutr        ISSN： 0277-2116            Impact factor:   2.839


  4 in total

Review 1.  Membrane transporters in drug development.

Authors:  Kathleen M Giacomini; Shiew-Mei Huang; Donald J Tweedie; Leslie Z Benet; Kim L R Brouwer; Xiaoyan Chu; Amber Dahlin; Raymond Evers; Volker Fischer; Kathleen M Hillgren; Keith A Hoffmaster; Toshihisa Ishikawa; Dietrich Keppler; Richard B Kim; Caroline A Lee; Mikko Niemi; Joseph W Polli; Yuichi Sugiyama; Peter W Swaan; Joseph A Ware; Stephen H Wright; Sook Wah Yee; Maciej J Zamek-Gliszczynski; Lei Zhang
Journal:  Nat Rev Drug Discov       Date:  2010-03       Impact factor: 84.694

2.  Case Report: Dubin-Johnson Syndrome Presenting With Infantile Cholestasis: An Overlooked Diagnosis in an Extended Family.

Authors:  Naglaa M Kamal; Omar Saadah; Hamdan Alghamdi; Ali Algarni; Mortada H F El-Shabrawi; Laila M Sherief; Salma A S Abosabie
Journal:  Front Pediatr       Date:  2022-05-25       Impact factor: 3.569

3.  Use of tc-99m mebrofenin as a clinical probe to assess altered hepatobiliary transport: integration of in vitro, pharmacokinetic modeling, and simulation studies.

Authors:  Giulia Ghibellini; Elaine M Leslie; Gary M Pollack; Kim L R Brouwer
Journal:  Pharm Res       Date:  2008-05-30       Impact factor: 4.200

4.  Transporter-Mediated Alterations in Patients With NASH Increase Systemic and Hepatic Exposure to an OATP and MRP2 Substrate.

Authors:  Izna Ali; Jason R Slizgi; Josh D Kaullen; Marija Ivanovic; Mikko Niemi; Paul W Stewart; Alfred S Barritt; Kim L R Brouwer
Journal:  Clin Pharmacol Ther       Date:  2017-12-22       Impact factor: 6.875
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.